Formation of isoprostanes in children with type IIa hypercholesterolemia

被引:8
作者
Cracowski, JL
Ploin, D
Bessard, J
Baguet, JP
Stanke-Labesque, F
Mallion, JH
Bost, M
Bessard, G
机构
[1] Grenoble Univ Hosp, Pharmacol Lab, Grenoble, France
[2] Grenoble Univ Hosp, Dept Pediat, Grenoble, France
[3] Grenoble Univ Hosp, Dept Internal Med & Cardiol, Grenoble, France
关键词
child; isoprostanes; hypercholesterolemia stress;
D O I
10.1097/00005344-200108000-00008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
F-2-isoprostanes are stable lipid peroxidation products of arachidonic acid and their quantification provides a novel approach to the assessment of oxidative stress in vivo. F-2-isoprostanes are present in increased amounts in adult hypercholesterolemia, but no data exist concerning children. We investigated urinary isoprostaglandin F-2 alpha type ill production as an index of lipid peroxidation in 15 children presenting with type IIa hypercholesterolemia (serum total cholesterol, 290 [SD +/- 70] mg/dl; low-density Lipoprotein cholesterol, 210 [SD +/- 90] mg/dl) compared with 15 sex- and age-paired control children (serum total cholesterol, 160 [SD +/- 20] mg/dl). Urinary levels of isoprostaglandin F-2 alpha type III were measured by gas chromatography mass spectrometry. Urinary concentrations did not differ significantly in hypercholesterolemic children compared with control children (84.7 [SD +/- 37] vs. 96 [SD +/- 35] pmol/mmol creatinine, respectively). No significant correlation was found with total cholesterol, low-density-lipoprotein and high-density-lipoprotein cholesterol, and apolipoprotein B and A(1) serum levels. F-2-isoprostane urinary levels in children with type IIa hypercholesterolemia do not differ from those of age- and sex-matched control children and are not correlated to blood lipid parameters, suggesting that hypercholesterolemia is not associated with increased lipid peroxidation in childhood.
引用
收藏
页码:228 / 231
页数:4
相关论文
共 18 条
  • [1] *AM AC PED, 1992, PEDIATRICS, V89, P525
  • [2] Determination of isoprostaglandin F2α type III in human urine by gas chromatography-electronic impact mass spectrometry.: Comparison with enzyme immunoassay
    Bessard, J
    Cracowski, JL
    Stanke-Labesque, F
    Bessard, G
    [J]. JOURNAL OF CHROMATOGRAPHY B, 2001, 754 (02): : 333 - 343
  • [3] NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS
    CELERMAJER, DS
    SORENSEN, KE
    GOOCH, VM
    SPIEGELHALTER, DJ
    MILLER, OI
    SULLIVAN, ID
    LLOYD, JK
    DEANFIELD, JE
    [J]. LANCET, 1992, 340 (8828) : 1111 - 1115
  • [4] Identification and measurement of endogenous β-oxidation metabolites of 8-epi-prostaglandin F2α
    Chiabrando, C
    Valagussa, A
    Rivalta, C
    Durand, T
    Guy, A
    Zuccato, E
    Villa, P
    Rossi, JC
    Fanelli, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) : 1313 - 1319
  • [5] COMINACINI L, 1994, NUTRITION, V10, P527
  • [6] In vivo formation of 8-epi-prostaglandin F-2 alpha is increased in hypercholesterolemia
    Davi, G
    Alessandrini, P
    Mezzetti, A
    Minotti, G
    Bucciarelli, T
    Costantini, F
    Cipollone, F
    Bon, GB
    Ciabattoni, G
    Patrono, C
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 3230 - 3235
  • [7] Prostaglandin F-2-like compounds, F-2-isoprostanes, are present in increased amounts in human atherosclerotic lesions
    Gniwotta, C
    Morrow, JD
    Roberts, LJ
    Kuhn, H
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 3236 - 3241
  • [8] Harris N, 1997, CLIN CHEM, V43, P816
  • [9] DYSLIPOPROTEINEMIA AND OTHER RISK-FACTORS FOR ATHEROSCLEROSIS IN CHILDREN AND ADOLESCENTS
    KWITEROVICH, PO
    [J]. ATHEROSCLEROSIS, 1994, 108 : S55 - S71
  • [10] KWITEROVICH PO, 1989, ARTERIOSCLER, V9, P111